GI
ETON icon

GAMMA Investing’s Eton Pharmaceutcials ETON Stock Holding History

GAMMA Investing’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$760 Hold
21
– – ﹤0.01% 3930
2026
Q1 		$518 Sell
21
-2
-9% -$35 ﹤0.01% 3943
2025
Q4 		$389 Buy
+23
New +$405 ﹤0.01% 3936

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

GAMMA Investing's ETON Position: Q2 2026 in Review

GAMMA Investing held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 21 shares worth $760. The position accounts for ﹤0.01% of the portfolio, ranked #3930.

GAMMA Investing first reported a position in ETON in Q4 2025 and has held it in 3 quarters since. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • GAMMA Investing held 21 shares of Eton Pharmaceutcials worth $760 as of Q2 2026.
  • GAMMA Investing left its Eton Pharmaceutcials share count unchanged in Q2 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3930 holding.
  • GAMMA Investing first reported a position in Eton Pharmaceutcials in Q4 2025 and has held it in 3 quarters since.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.